Metabolic effects of replacing sugar-sweetened beverages with artificially-sweetened beverages in overweight subjects with or without hepatic steatosis: A randomized control clinical trial

Nutrients

Volumn 9, Issue 3, 2017, Pages

  Campos, Vanessa ^a   Despland, Camille ^a   Brandejsky, Vaclav ^b   Kreis, Roland ^b   Schneiter, Philippe ^a   Boesch, Chris ^b   Tappy, Luc ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cardiovascular risk factors; Fructose; Hypertriglyceridemia; Intrahepatocellular lipid concentration

Indexed keywords

FATTY ACID; FRUCTOSE; GLUCAGON; GLUCOSE; INSULIN; LACTIC ACID; TRIACYLGLYCEROL; URIC ACID; GLUCOSE BLOOD LEVEL; NUTRITIVE SWEETENER; SWEETENING AGENT;

ADULT; ARTICLE; ARTIFICIALLY SWEETENED BEVERAGE; BLOOD SAMPLING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FATTY LIVER; FEMALE; FOOD INTAKE; HUMAN; INTRAPERITONEAL FAT; MALE; MASS FRAGMENTOGRAPHY; METABOLISM; OBESITY; PHYSICAL ACTIVITY; PROTON NUCLEAR MAGNETIC RESONANCE; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; SUGAR-SWEETENED BEVERAGE; URINALYSIS; BLOOD; BODY MASS; DIET; GLUCOSE BLOOD LEVEL; MEAL; POSTPRANDIAL STATE; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIET; FATTY ACIDS, NONESTERIFIED; FATTY LIVER; FEMALE; GLUCAGON; HUMANS; INSULIN; LACTIC ACID; MALE; MEALS; NUTRITIVE SWEETENERS; OBESITY; OVERWEIGHT; POSTPRANDIAL PERIOD; SWEETENING AGENTS; TREATMENT OUTCOME; TRIGLYCERIDES; URIC ACID; YOUNG ADULT;

EID: 85014232767     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9030202     Document Type: Article

References (32)

1. Bray, G.; Nielsen, S.; Popkin, B. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am. J. Clin. Nutr. 2004, 79, 737–743.
2. Bray, G.A. Soft drink consumption and obesity: It is all about fructose. Curr. Opin. Lipidol. 2010, 21, 51–57. [CrossRef] [PubMed]
3. Malik, V.S.; Popkin, B.M.; Bray, G.A.; Despres, J.P.; Hu, F.B. Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 2010, 121, 1356–1364. [CrossRef] [PubMed]
4. Tappy, L.; Le, K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol. Rev. 2010, 90, 23–46. [CrossRef] [PubMed]
5. Chiu, S.; Sievenpiper, J.L.; de Souza, R.J.; Cozma, A.I.; Mirrahimi, A.; Carleton, A.J.; Ha, V.; Di Buono, M.; Jenkins, A.L.; Leiter, L.A.; et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis of controlled feeding trials. Eur. J. Clin. Nutr. 2014, 68, 416–423. [CrossRef] [PubMed]
6. Alwahsh, S.M.; Gebhardt, R. Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD). Arch. Toxicol. 2016. [CrossRef] [PubMed]
7. Campos, V.; Despland, C.; Brandejsky, V.; Kreis, R.; Schneiter, P.; Chiolero, A.; Boesch, C.; Tappy, L. Sugar- and artificially sweetened beverages and intrahepatic fat: A randomized controlled trial. Obesity (Silver Spring) 2015, 23, 2335–2339. [CrossRef] [PubMed]
8. Stanhope, K.L. Role of fructose-containing sugars in the epidemics of obesity and metabolic syndrome. Annu. Rev. Med. 2012, 63, 329–343. [CrossRef] [PubMed]
9. Johnson, R.J.; Nakagawa, T.; Sanchez-Lozada, L.G.; Shafiu, M.; Sundaram, S.; Le, M.; Ishimoto, T.; Sautin, Y.Y.; Lanaspa, M.A. Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013, 62, 3307–3315. [CrossRef] [PubMed]
10. Lustig, R.H.; Schmidt, L.A.; Brindis, C.D. Public health: The toxic truth about sugar. Nature 2012, 482, 27–29. [CrossRef] [PubMed]
11. Schwarz, J.M.; Noworolski, S.M.; Wen, M.J.; Dyachenko, A.; Prior, J.L.; Weinberg, M.E.; Herraiz, L.A.; Tai, V.W.; Bergeron, N.; Bersot, T.P.; et al. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat. J. Clin. Endocrinol. Metab. 2015, 100, 2434–2442. [CrossRef] [PubMed]
12. Teff, K.L.; Grudziak, J.; Townsend, R.R.; Dunn, T.N.; Grant, R.W.; Adams, S.H.; Keim, N.L.; Cummings, B.P.; Stanhope, K.L.; Havel, P.J. Endocrine and metabolic effects of consuming fructose- and glucose-sweetened beverages with meals in obese men and women: Influence of insulin resistance on plasma triglyceride responses. J. Clin. Endocrinol. Metab. 2009, 94, 1562–1569. [CrossRef] [PubMed]
13. Lonardo, A.; Ballestri, S.; Marchesini, G.; Angulo, P.; Loria, P. Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome. Dig. Liver Dis. 2015, 47, 181–190. [CrossRef] [PubMed]
14. Theytaz, F.; de Giorgi, S.; Hodson, L.; Stefanoni, N.; Rey, V.; Schneiter, P.; Giusti, V.; Tappy, L. Metabolic fate of fructose ingested with and without glucose in a mixed meal. Nutrients 2014, 6, 2632–2649. [CrossRef] [PubMed]
15. Bucher, J.; Krusi, M.; Zueger, T.; Ith, M.; Stettler, C.; Diem, P.; Boesch, C.; Kreis, R.; Christ, E. The effect of a single 2 h bout of aerobic exercise on ectopic lipids in skeletal muscle, liver and the myocardium. Diabetologia 2014, 57, 1001–1005. [CrossRef] [PubMed]
16. Swinburn, B.A.; Sacks, G.; Hall, K.D.; McPherson, K.; Finegood, D.T.; Moodie, M.L.; Gortmaker, S.L. The global obesity pandemic: Shaped by global drivers and local environments. Lancet 2011, 378, 804–814. [CrossRef]
17. Swinburn, B.A.; Sacks, G.; Lo, S.K.; Westerterp, K.R.; Rush, E.C.; Rosenbaum, M.; Luke, A.; Schoeller, D.A.; DeLany, J.P.; Butte, N.F.; et al. Estimating the changes in energy flux that characterize the rise in obesity prevalence. Am. J. Clin. Nutr. 2009, 89, 1723–1728. [CrossRef] [PubMed]
18. Singh, G.M.; Micha, R.; Khatibzadeh, S.; Lim, S.; Ezzati, M.; Mozaffarian, D. Global Burden of Diseases Nutrition; Chronic Diseases Expert Group. Estimated Global, Regional, and National Disease Burdens Related to Sugar-Sweetened Beverage Consumption in 2010. Circulation 2015. [CrossRef]
19. Pan, A.; Hu, F.B. Effects of carbohydrates on satiety: Differences between liquid and solid food. Curr. Opin. Clin. Nutr. Metab. Care 2011, 14, 385–390. [CrossRef] [PubMed]
20. Campos, V.C.; Tappy, L. Physiological handling of dietary fructose-containing sugars: Implications for health. Int. J. Obes. (Lond.) 2016, 40 (Suppl. 1), S6–S11. [CrossRef] [PubMed]
21. Egli, L.; Lecoultre, V.; Theytaz, F.; Campos, V.; Hodson, L.; Schneiter, P.; Mittendorfer, B.; Patterson, B.W.; Fielding, B.A.; Gerber, P.A.; et al. Exercise prevents fructose-induced hypertriglyceridemia in healthy young subjects. Diabetes 2013, 62, 2259–2265. [CrossRef] [PubMed]
22. Stanhope, K.L.; Bremer, A.A.; Medici, V.; Nakajima, K.; Ito, Y.; Nakano, T.; Chen, G.; Fong, T.H.; Lee, V.; Menorca, R.I.; et al. Consumption of fructose and high fructose corn syrup increase postprandial triglycerides, LDL-cholesterol, and apolipoprotein-B in young men and women. J. Clin. Endocrinol. Metab. 2011, 96, E1596–E1605. [CrossRef] [PubMed]
23. Stanhope, K.L.; Medici, V.; Bremer, A.A.; Lee, V.; Lam, H.D.; Nunez, M.V.; Chen, G.X.; Keim, N.L.; Havel, P.J. A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults. Am. J. Clin. Nutr. 2015, 101, 1144–1154. [CrossRef] [PubMed]
24. Van den Berghe, G. Inborn errors of fructose metabolism. Annu. Rev. Nutr. 1994, 14, 41–58. [CrossRef] [PubMed]
25. Hu, Q.H.; Wang, C.; Li, J.M.; Zhang, D.M.; Kong, L.D. Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: Renal organic ion transporter involvement. Am. J. Physiol. Ren. Physiol. 2009, 297, F1080–F1091. [CrossRef] [PubMed]
26. Lecoultre, V.; Egli, L.; Theytaz, F.; Despland, C.; Schneiter, P.; Tappy, L. Fructose-induced hyperuricemia is associated with a decreased renal uric Acid excretion in humans. Diabetes Care 2013, 36, e149–e150. [CrossRef] [PubMed]
27. Jin, R.; Welsh, J.A.; Le, N.A.; Holzberg, J.; Sharma, P.; Martin, D.R.; Vos, M.B. Dietary fructose reduction improves markers of cardiovascular disease risk in Hispanic-American adolescents with NAFLD. Nutrients 2014, 6, 3187–3201. [CrossRef] [PubMed]
28. Lustig, R.H.; Mulligan, K.; Noworolski, S.M.; Tai, V.W.; Wen, M.J.; Erkin-Cakmak, A.; Gugliucci, A.; Schwarz, J.M. Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome. Obesity (Silver Spring) 2016, 24, 453–460. [CrossRef] [PubMed]
29. Te Morenga, L.; Mallard, S.; Mann, J. Dietary sugars and body weight: Systematic review and meta-analyses of randomised controlled trials and cohort studies. Br. Med. J. 2013, 346, e7492. [CrossRef] [PubMed]
30. Malik, V.S.; Pan, A.; Willett, W.C.; Hu, F.B. Sugar-sweetened beverages and weight gain in children and adults: A systematic review and meta-analysis. Am. J. Clin. Nutr. 2013, 98, 1084–1102. [CrossRef] [PubMed]
31. De Ruyter, J.C.; Olthof, M.R.; Seidell, J.C.; Katan, M.B. A Trial of Sugar-free or Sugar-Sweetened Beverages and Body Weight in Children. N. Engl. J. Med. 2012. [CrossRef] [PubMed]
32. Katan, M.B.; de Ruyter, J.C.; Kuijper, L.D.; Chow, C.C.; Hall, K.D.; Olthof, M.R. Impact of Masked Replacement of Sugar-Sweetened with Sugar-Free Beverages on Body Weight Increases with Initial BMI: Secondary Analysis of Data from an 18 Month Double-Blind Trial in Children. PLoS ONE 2016, 11, e0159771. [CrossRef] [PubMed]